Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ CSRP3 Polyclonal Antibody
Goat Polyclonal Antibody
Supplier: Invitrogen™ PA519062
Description
This antibody is predicted to react with bovine and canine based on sequence homology. This antibody is tested in Peptide ELISA: antibody detection limit dilution 32,000.
This gene encodes a member of the CSRP family of LIM domain proteins, which may be involved in regulatory processes important for development and cellular differentiation. The LIM/double zinc-finger motif found in this protein is found in a group of proteins with critical functions in gene regulation, cell growth, and somatic differentiation. Mutations in this gene are thought to cause heritable forms of hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM) in humans. Alternatively spliced transcript variants with different 5' UTR, but encoding the same protein, have been found for this gene.
Specifications
CSRP3 | |
Polyclonal | |
Unconjugated | |
Csrp3 | |
cardiac LIM domain protein; cardiac LIM protein; Clp; CMD1M; CMH12; CRP3; Csrp3; cysteine and glycine rich protein 3; cysteine and glycine-rich protein 3; cysteine and glycine-rich protein 3 (cardiac LIM protein); cysteine-rich protein 3; LIM domain only 4; LIM domain protein, cardiac; LMO4; MGC14488; MGC61993; MLP; MMLP; Muscle LIM protein; muscle lim protein isoform | |
Goat | |
Ammonium sulfate precipitation | |
RUO | |
117505, 13009, 8048 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot | |
0.5 mg/mL | |
TBS with 0.5% BSA and 0.02% sodium azide; pH 7.3 | |
P50461, P50462, P50463 | |
Csrp3 | |
Synthetic peptide sequence (CGKSLESTNVTDKD) corresponding to the internal amino acids of CSRP3 (aa 150-163). | |
100 μg | |
Primary | |
Human, Mouse, Rat | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction